Ikonisys S.A. (EPA:ALIKO)
France · Delayed Price · Currency is EUR 1.450
+0.010 (0.69%)
Nov 10, 2025, 5:23 PM CET
Ikonisys Revenue
In the year 2024, Ikonisys had annual revenue of 1.01M EUR with 56.72% growth. Ikonisys had revenue of 713.57K in the half year ending December 31, 2024, with 74.19% growth.
Revenue
1.01M
Revenue Growth
+56.72%
P/S Ratio
20.11
Revenue / Employee
67.41K
Employees
15
Market Cap
20.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.01M | 365.94K | 56.72% |
| Dec 31, 2023 | 645.17K | 28.31K | 4.59% |
| Dec 31, 2022 | 616.87K | 74.17K | 13.67% |
| Dec 31, 2021 | 542.70K | 57.53K | 11.86% |
| Dec 31, 2020 | 485.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |